Conferences - Results from #20

PSMA and Beyond 2025: PSMA RLT in a Medical Oncology Private Center March 29, 2025

PSMA and Beyond 2025: Ac225 PSMA Experience March 29, 2025

PSMA and Beyond 2025: 212Pb-PSMA vs 225Ac-PSMA: from Biology to Supply March 29, 2025

PSMA and Beyond 2025: Impact of Clinical Guidelines on the Utilization of PSMA PET March 29, 2025

PSMA and Beyond 2025: Incorporating PSMA PET into Clinical Trials March 29, 2025

PSMA and Beyond 2025: Landscape of Approved PSMA Imaging Agents: Does It Matter? March 29, 2025

PSMA and Beyond 2025: Moving into the Castration Sensitive Setting March 29, 2025

PSMA and Beyond 2025: Overview of Clinical Trials of PSMA RLT in 2025 March 29, 2025

PSMA and Beyond 2025: How to Crush a PSMA PET Report: Guidelines and Scoring Systems March 29, 2025

PSMA and Beyond 2025: Post-VISION: Real World Experience in the US, How Is PSMA RLT Being Used? March 29, 2025

PSMA and Beyond 2025: Can We Kill the Bone Scan? March 29, 2025

PSMA and Beyond 2025: Pre-chemo Trials: PSMAfore/SPLASH/ECLIPSE March 29, 2025

PSMA and Beyond 2025: PRIMARY Score and Where it Plays a Role March 29, 2025

PSMA and Beyond 2025: Can PSMA-Targeted Prostate Biopsy Detect Cancer When MRI-Guided Biopsy is Negative? March 29, 2025

PSMA and Beyond 2025: PSMA RLT for Oligometastatic Disease March 29, 2025

PSMA and Beyond 2025: Role of PSMA PET in Surgical Planning and Post-Operative Management March 29, 2025

PSMA and Beyond 2025: PSMA-PET for Overall Survival Outcome Risk Stratification of Prostate Cancer March 29, 2025

PSMA and Beyond 2025: Treatment Sequencing with Radioligand Therapy in mCRPC March 29, 2025

PSMA and Beyond 2025: Whole Body PSMA Quantitative Parameters: Why Are We Not Using Whole Body PSMA PET Parameters in the Real World March 29, 2025

PSMA and Beyond 2025: What’s the Best Way to Evaluate Response: SPECT vs PSMA PET? March 29, 2025

Page 2 of 616